Skip to main content

Table 5 Results of regression models: Regression coefficients of AATD patients with and without AT

From: Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients

Regression coefficients

 

HRQL

 

SGRQ

CAT

EQ-5D-3 L utility

EQ-5D VAS

Group

A

Ref.

Ref.

Ref.

Ref.

B1

2.68 (−0.82 – 6.19)

0.66 (−0.73 – 2.04)

−0.55 (−4.45 – 3.35)

−1.58 (−5.23 – 2.07)

B2

−0.64 (−7.53 – 6.24)

0.60 (−2.09 – 3.31)

−1.67 (−9.34 – 6.00)

2.14 (−5.01 – 9.30)

  1. Group A = COPD patients without Alpha-1-antitrypsin deficiency (AATD), Group B1 = COPD patients with AATD and augmentation therapy (AT), B2 = COPD patients with AATD but without augmentation therapy
  2. EQ-5D-3 L utility was multiplied by 100
  3. Significant estimates on a level of p < 0.05 are printed bold
Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us